American actor Matthew Perry tragically passed away on October 28 at the age of 54 due to the acute effects of ketamine. A recent ruling by a judge has set the stage for a trial in March 2025 involving a woman known as the 'Queen of Ketamine' and a doctor linked to Perry's death. Reports indicate that the actor had been struggling with addiction after seeking treatment for depression and anxiety, leading him to intravenous ketamine as a form of relief.
Perry's death has raised serious questions about the practices of medical professionals in the treatment of addiction. Allegations have surfaced that Dr. Salvador Plasencia, based in Santa Monica, employed Perry's live-in assistant to administer ketamine doses, reportedly for a staggering $55,000. The assistant and Plasencia are expected to face trial alongside Jasvin Sangha, who is accused of selling ketamine to the actor for $11,000. This case highlights the potential exploitation of vulnerable individuals seeking help for their mental health issues.
- The trial scheduled for March 4, 2025, will examine the circumstances surrounding Perry's death and the actions of those involved in his treatment. The involvement of ketamine, a drug often used for depression treatment, raises critical discussions about the ethics of its administration, especially when it comes to individuals with a history of substance abuse. As the case unfolds, it will draw attention to the broader issues of addiction treatment and the responsibilities of healthcare providers.
